Medadvisor Ltd (MDR) — Capital Reinvestment Ratio

Latest as of December 2023: 0.07x

Medadvisor Ltd (MDR) has a Capital Reinvestment Ratio of 0.07x as of December 2023, meaning it reinvests 0% of its operating cash flow (AU$11.04 Million) in capital expenditures (AU$821.44K). Check tangible net worth ratio of Medadvisor Ltd to evaluate the tangible quality of the company's equity base.

Capital Reinvestment Ratio

0.07x

Capex / Operating Cash Flow

Operating Cash Flow

AU$11.04 Million

AUD

Capital Expenditures

AU$821.44K

AUD

Data as of

Dec 2023

Most recent filing

Medadvisor Ltd Capital Reinvestment Ratio (2024–2024)

This chart tracks Medadvisor Ltd's Capital Reinvestment Ratio across 1 annual periods. For the full cash flow conversion analysis, see Medadvisor Ltd (MDR) cash conversion ratio.

Annual Capital Reinvestment Ratio for Medadvisor Ltd (2024–2024)

Year-by-year Capital Reinvestment Ratio for Medadvisor Ltd from 2024 to 2024. See MDR free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Year	Reinvestment Ratio	Operating CF (AUD)	Capital Expenditures	YoY Change
2024	0.35x	AU$5.19 Million	AU$1.83 Million	—

Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow